3Billion EBITDA per Employee

What does 3Billion do? 3Billion Inc provides genetic testing services, focusing on rare genetic disease diagnostic testing. The company develops technology to automatically read the pathogenicity of genetic variants in the genome. Its primary products are diagnostic testing services and R&D technology for genetic variants. The target customers are medical institutions and healthcare providers requiring genetic diagnostics. The company operates in the healthcare sector, specifically in genetic diagnostics and research. 3Billion Inc's revenue comes from offering diagnostic testing services to healthcare facilities and licensing its R&D technology. The firm serves medical institutions seeking accurate genetic disease diagnosis and research institutions developing genetic analysis tools. The company's services support both clinical diagnostics and scientific research in genomics. The business model centers on two main revenue streams: direct sales of genetic diagnostic services and technology licensing. Healthcare providers purchase diagnostic testing to identify rare genetic conditions, while research organizations license the automatic pathogenicity reading technology for genomic studies. The company's focus on rare genetic diseases differentiates its offerings in the medical diagnostics market. 3Billion is one of the most popular companies on Eulerpool.